UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000046923
Receipt No. R000053535
Scientific Title Study on life and physical prognosis of hospitalized patients with aspiration pneumonia
Date of disclosure of the study information 2022/02/17
Last modified on 2022/08/19 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on life and physical prognosis of hospitalized patients with aspiration pneumonia
Acronym Study on life and physical prognosis of hospitalized patients with aspiration pneumonia
Scientific Title Study on life and physical prognosis of hospitalized patients with aspiration pneumonia
Scientific Title:Acronym Study on life and physical prognosis of hospitalized patients with aspiration pneumonia
Region
Japan

Condition
Condition aspiration pneumonia
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the life and physical prognosis of patients with aspiration pneumonia
Basic objectives2 Others
Basic objectives -Others Explain for factors that influence life and physical prognosis
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes 90-day survival
Key secondary outcomes ability to walk

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria All cases
Key exclusion criteria None
Target sample size 330

Research contact person
Name of lead principal investigator
1st name Yorihide
Middle name
Last name Yanagita
Organization Seirei Mikatahara General Hospital
Division name Department of Rehabilitation Medicine
Zip code 4338558
Address 3453, Mikatahara-cho, Hamamatsu City, Shizuoka Prefecture
TEL 053-436-1251
Email dependonhero@yahoo.co.jp

Public contact
Name of contact person
1st name Yorihide
Middle name
Last name Yanagita
Organization Seirei Mikatahara General Hospital
Division name Department of Rehabilitation Medicine
Zip code 4338558
Address 3453, Mikatahara-cho, Hamamatsu City, Shizuoka Prefecture
TEL 053-436-1251
Homepage URL
Email dependonhero@yahoo.co.jp

Sponsor
Institute Seirei Mikatahara General Hospital, Department of Rehabilitation Medicine
Institute
Department

Funding Source
Organization Seirei Mikatahara General Hospital, Department of Rehabilitation Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Seirei Mikatahara General Hospital
Address 3453, Mikatahara-cho, Hamamatsu City, Shizuoka Prefecture
Tel 053-436-1251
Email dependonhero@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 02 Month 17 Day

Related information
URL releasing protocol https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902237347483549
Publication of results Unpublished

Result
URL related to results and publications https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201902237347483549
Number of participants that the trial has enrolled 333
Results In total, 333 consecutive patients with aspiration pneumonitis were screened for eligibility, of whom 276 (82.9%) were recruited for the study.
There were 231 survivors and 45 non-survivors. There were significant differences in 11 items in the comparison between the two groups.
Multivariate logistic regression model results showed that A-DROP score, GNRI score, and gender were independent early predictors of mortality.
Results date posted
2022 Year 02 Month 16 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics Patients admitted to hospital with swallowing pneumonia
Participant flow Patients were included in the study by being hospitalized. At Seirei Mikatahara General Hospital, we explained the unintended use of medical records at the time of the first visit using oral and written information. In this study, we only included patients in which informed consent was obtained for the unintended use of medical records.
Adverse events None
Outcome measures 90-day survival
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 02 Month 01 Day
Date of IRB
2017 Year 12 Month 15 Day
Anticipated trial start date
2015 Year 04 Month 01 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
2018 Year 01 Month 01 Day
Date trial data considered complete
2018 Year 01 Month 01 Day
Date analysis concluded
2022 Year 07 Month 06 Day

Other
Other related information Patient information of all patients hospitalized with aspiration pneumonia over a 1-year period was analyzed.

Management information
Registered date
2022 Year 02 Month 16 Day
Last modified on
2022 Year 08 Month 19 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000053535